Genomic Vision (GV.PA) Stock Earnings Estimates

Europe • Euronext Paris • EPA:GV • FR0011799907

0.0018 EUR
+0 (+5.88%)
Last: Nov 3, 2023, 07:00 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2020 2021 2022
Revenue
YoY % growth
GV.PA revenue by date.GV.PA revenue by date.
1.084M
-38.76%		994K
-8.30%		1.026M
3.22%
EBITDA
YoY % growth
GV.PA ebitda by date.GV.PA ebitda by date.
-4.788M
-4.75%		-4.664M
2.59%		-5.436M
-16.55%
EBIT
YoY % growth
GV.PA ebit by date.GV.PA ebit by date.
-5.377M
-15.66%		-4.895M
8.96%		-6.122M
-25.07%
Operating Margin
GV.PA operating margin by date.GV.PA operating margin by date.
-496.03%-492.45%-596.69%
EPS
YoY % growth
GV.PA eps by date.GV.PA eps by date.
N/AN/AN/A

All data in EUR

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in EUR

Recent Earnings VS Estimates Surprises (EUR)
PeriodReportedEstimateDifferenceSurprise
GV.PA Yearly EPS VS EstimatesGV.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 -0.5 -1 -1.5
Recent Revenue VS Estimates Surprises (EUR)
PeriodReportedEstimateDifferenceSurprise
Q2 2023
Q2Q % growth		 593K
16.05%		%
Q4 2022
Q2Q % growth		 515K
-2.28%		%
Q2 2022
Q2Q % growth		 511K
9.42%		%
Q4 2021
Q2Q % growth		 527K
12.13%		%
Q2 2021
Q2Q % growth		 467K
-24.68%		%
GV.PA Yearly Revenue VS EstimatesGV.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 1M 2M 3M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A N/A N/A
RevenueN/A N/A N/A N/A